Home /  Courses And Programs / CT: Drug Safety: Surveillance and Reporting


Common issues and concerns associated with drug safety surveillance within the clinical trial are the focus of this course. Topics include the defining and identifying adverse experiences, verifying drug safety, regulations regarding surveillance of investigational and marketed products, safety reporting requirements, analyzing study results to determine safety, and required actions in the event of safety issues. Useful from both site and sponsor perspectives.

Other Credits : BRN, BBS: 16 CE hours.

  • NOTE  Elective for Professional Certificate in Clinical Trials Design and Management.

  • COURSE NUMBER  FPM-40206
  • CREDIT  2.00 unit(s)


Popular in Clinical Trials & Regulatory Affairs

course

CT: Medical Writing: Protocols, Reports, Summaries, and Submissions

Read More
certificate

Clinical Trials Design and Management

Read More
course

Good Documentation Practices

Read More
course

CT: Human Subjects Protection and IRBs

Read More
course

In Vitro Diagnostics Product Development

Read More
course

CT: Drug Development Process

Read More
course

Regulatory Compliance for Drugs & Biologics

Read More
course

CT: Practical Clinical Statistics for the Non-Statistician

Read More
course

Good Manufacturing Practices

Read More
course

Navigating The Genomic Regulatory Landscape

Read More
category

Clinical Trials & Regulatory Affairs

Read More

Certificate Programs

Clinical Trials Design and Management

From the Blog